1. Clinical Features of Scleritis Across the Asia-Pacific Region.
- Author
-
Lane J, Nyugen E, Morrison J, Lim L, Stawell R, Hodgson L, Bin Ismail MA, Ling HS, Teoh S, Agrawal R, Mahendradas P, Hari P, Gowda PB, Kawali A, and McCluskey PJ
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Asian People ethnology, Australia epidemiology, Child, Female, Humans, Immunosuppressive Agents therapeutic use, India epidemiology, Male, Middle Aged, Retrospective Studies, Scleritis diagnosis, Scleritis drug therapy, Sex Distribution, Singapore epidemiology, Visual Acuity, Young Adult, Scleritis epidemiology, Tertiary Care Centers statistics & numerical data
- Abstract
Purpose : To examine the spectrum of scleritis in four tertiary institutions across the Asia-Pacific. Methods : Clinical records from 354 patients were reviewed from centers in Australia, Singapore, and India, excluding those with insufficient data ( n = 24). Results : Indian patients presented younger (41.5 ± 13.4 years) than Australians (50.8 ± 17.5) and Singaporeans (48.6 ± 15.9), with fewer women (49% vs 62%/57%). Diffuse disease was universally most common. Autoimmune and infectious disease proportions were similar in Australia (31%/10.3%) and Singapore (27.5%/8.3%) but reversed in India (8.3%/30%). Necrotizing scleritis was most frequently associated with infection (27.3%). Presumed ocular tuberculosis accounted for 75% of infectious cases in India. Posterior scleritis had the highest complication rate (82.4%) and immunosuppressants used per patient (0.98 ± 0.31 95% CI). Conclusions : Clinical presentations of scleritis vary across the Asia-Pacific, particularly in endemic regions for tuberculosis such as India, where it affects younger men with a predominance of nodular and infectious disease.
- Published
- 2019
- Full Text
- View/download PDF